ArticleHealth and quality of life outcomes2026
The Uncertainty in Illness Questionnaire (UIQ): development and validation of a clinically oriented measure for patients and caregivers.
Article in Health and quality of life outcomes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Editorial: Advancing measurement validity in clinical and dynamic psychology.Frontiers in psychology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe present research aimed to develop and validate the Uncertainty in Illness Questionnaire (UIQ), a self-report tool designed to assess uncertainty in illness (UI) among Italian-speaking patients and caregivers. Across three studies, the psychometric properties of the UIQ were rigorously evaluated in large, diverse samples. METHODS &
resultsIn Study 1, the novel exploratory graph analysis (EGA) revealed a robust four-factor structure - uncertainty about symptoms, treatments, future change, and relationships (optimal stability > .90, negligible cross-loadings). Such structure was then confirmed in Study 2, in an independent sample, through confirmatory factor analysis (CFA) with a hierarchical model with four first-order factors showing good fit (robust RMSEA = 0.065[90% CI: 0.056-0.075]; robust CFI=0.958; robust TLI=0.949; SRMR=0.043). UIQ demonstrated strong reliability, internal consistency, and both convergent and divergent validity. Measurement invariance analyses reached latent means invariance, revealing that UIQ is interpreted equivalently by patients and caregivers, supporting meaningful group comparisons. Following recent methodological guidelines, Study 3 demonstrated the discriminant validity of the UIQ with the Intolerance of Uncertainty Scale-Revised, measuring dispositional intolerance of uncertainty.
conclusionsThe tool's brevity and clarity make it suitable for both clinical and research settings, especially where respondent burden must be minimized. The UIQ addresses an important gap in the Italian context, providing a validated, context-specific measure of UI. Convenience sampling, predominantly female participants (> 85%), cross-sectional design, and lack of clinical subgroup analyses limit generalizability. The tool requires cross-cultural validation beyond Italian-speaking populations. UIQ offers clinicians and researchers a reliable means to assess and address UI, ultimately supporting tailored interventions to improve psychological health in medical contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.